In most businesses it is considered bad form to knock the competition. Moreso in healthcare where people lives are potentially at stake.

You would think Joe could have the same patience he is asking investors to have. For a company than has a proven track record of bringing no vaccine to market and miserably failing to capitalize on its Oral-lyn platform would be a bit more reserved in providing public comments on others successes.